RecruitingNCT07693283

Expression of Target in Endometriotic Lesions

To Investigate the Expression of Target in Endometriotic Lesions


Sponsor

Beijing Tsinghua Chang Gung Hospital

Enrollment

40 participants

Start Date

Apr 13, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Retrospective molecular expression analysis in endometriosis tissue specimens for people with endometriosis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRetrospective molecular expression analysis in endometriosis tissue specimens

This study involves no prospective interventional measures for participants.


Locations(1)

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07693283


Related Trials